Our results indicate that neutralizing antibody titres, as well as antibodies binding to whole-virion, S1-, RBD- and nucleocapsid proteins are highest in early convalescent sera of COVID-19 patients with severe symptoms, as compared to patients with mild symptoms. This evidence concerns the gene PSMD1 and COVID-19.